NDC 59762-5007-01 - misoprostol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-5007
- Requested NDC
- 59762-5007-01
- Package NDCs from labels
- 59762-5007-1, 59762-5007-2, 59762-5007-01
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2026-08-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Misoprostol Tablets | Mylan Pharmaceuticals Inc. | 2026-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| misoprostol - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-06-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Misoprostol Tablets | PD-Rx Pharmaceuticals, Inc. | 2023-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Misoprostol Tablets | H.J. Harkins Company, Inc. | 2012-01-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-5007-1 | misoprostol | 60 in 1 BOTTLE | TABLET | 60 | 15 | |
| 59762-5007-2 | misoprostol | 120 in 1 BOTTLE | TABLET | 120 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-5007 | MISOPROSTOL TABLET [MYLAN PHARMACEUTICALS INC.] | 14 | Current NDC, Legacy NDC, 2 package rows | 20250525_c4fe14fb-0a43-4c31-9cd6-29eb0d156705.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-5007-1 | EA - Each | 59762-5007 | 2fc7a1b3-980b-43d2-b991-4858f271b2fa | 1 | 2012-07-24 |
| 59762-5007-2 | EA - Each | 59762-5007 | 4fe02fd7-6d64-41dc-a108-b76dbacfd46c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MISOPROSTOL | ACTIVE INGREDIENT | 0E43V0BB57 | MISOPROSTOL TABLET [GREENSTONE LLC] | 7 | |
| MISOPROSTOL | ACTIVE MOIETY | 0E43V0BB57 | MISOPROSTOL TABLET [GREENSTONE LLC] | 7 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MISOPROSTOL TABLET [GREENSTONE LLC] | 7 | |
| HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | ZF94AP8MEY | MISOPROSTOL TABLET [GREENSTONE LLC] | 7 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | MISOPROSTOL TABLET [GREENSTONE LLC] | 7 | |
| misoprostol | ACTIVE INGREDIENT | 0E43V0BB57 | MISOPROSTOL TABLET [H.J. HARKINS COMPANY, INC.] | 2 | |
| misoprostol | ACTIVE MOIETY | 0E43V0BB57 | MISOPROSTOL TABLET [H.J. HARKINS COMPANY, INC.] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | MISOPROSTOL TABLET [H.J. HARKINS COMPANY, INC.] | 2 | |
| hydrogenated castor oil | INACTIVE INGREDIENT | ZF94AP8MEY | MISOPROSTOL TABLET [H.J. HARKINS COMPANY, INC.] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | MISOPROSTOL TABLET [H.J. HARKINS COMPANY, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rite Aid Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Rite Aid Corporation | fa1b5b66-9643-e9a7-e053-6394a90ae3cf | 2023-12-23 | Warnings | 3NXW29V3WO |
| Meijer Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Meijer Distribution, Inc. | 9feaa5e2-6aca-96e8-e053-2a95a90a54bd | 2023-12-22 | Warnings | 3NXW29V3WO |
| Walgreens Multi-Symptom Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Walgreen Co. | a03789ce-66bd-7b12-e053-2995a90af85a | 2023-12-20 | Warnings | 3NXW29V3WO |
| Walgreens Lubricant Eye Drops Preservative Free | DEXTRAN 70, HYPROMELLOSE | Walgreen Company | 9b383e41-e116-1c12-e053-2a95a90ab25f | 2023-12-20 | Warnings | 3NXW29V3WO |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | 3NXW29V3WO |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | 3NXW29V3WO |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | 3NXW29V3WO |
| Misoprostol | MISOPROSTOL | Proficient Rx LP | 85410e16-d164-4666-9539-778e2b4dd138 | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 317128 0E43V0BB57 |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | ZF94AP8MEY |
| Misoprostol | MISOPROSTOL | GenBioPro, Inc. | 2f4d6f06-529c-4b54-908a-0db4c18aff67 | 2023-01-06 | Boxed warning, Warnings, Adverse reactions | 317128 0E43V0BB57 |
| Misoprostol | MISOPROSTOL | PharmPak, Inc. | b07b3dfc-1cb5-484c-be11-8d14c89c794f | 2022-10-08 | Boxed warning, Warnings, Adverse reactions | 317128 0E43V0BB57 |
| Diclofenac Sodium Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Proficient Rx LP | 33f7db0b-f049-4d2e-abf5-4db97222e175 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | 0E43V0BB57 |
| Misoprostol | MISOPROSTOL | Lupin Pharmaceuticals,Inc. | 14f73ae3-7d8d-4d10-b668-8bd5adf8032c | 2020-12-21 | Boxed warning, Warnings, Adverse reactions | 311727 317128 0E43V0BB57 |
| Misoprostol | MISOPROSTOL | Novel Laboratories, Inc. | a46d05a2-5014-40ff-8f1b-9eca1b0aff3a | 2020-12-21 | Boxed warning, Warnings, Adverse reactions | 311727 317128 0E43V0BB57 |
| 9355aee3-c2a5-485f-ae95-cf93bfc0a57f | a5e5413d-bc22-4ae1-959b-0eb0430dbd38 | 2012-01-19 | Boxed warning, Warnings, Adverse reactions | 9355aee3-c2a5-485f-ae95-cf93bfc0a57f a5e5413d-bc22-4ae1-959b-0eb0430dbd38 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.